Impact of a blend of four Alkalihalobacillus clausii strains (O/C, N/R, SIN, and T) on gut barrier integrity and immune modulation with PPIs: An invitro SHIME study
Letters in Applied Microbiology · 2026
DOI: 10.1093/lambio/ovag025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2026. Verfasst von Lynn Verstrepen und 4 weiteren Autor:innen. Beteiligte Einrichtung: ProDigest BV, 9052 Zwijnaarde, Belgium. Hauptthemen laut MEDLINE: Probiotics, Bacillaceae, Immunomodulation. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Opella, Sanofi Consumer Healthcare.
Abstract (Originalsprache)
Alkalihalobacillus clausii is effective in alleviating PPI-induced dysbiosis; however, its effects on gut barrier function and inflammation remain unclear. This study explored A. clausii (O/C, N/R, SIN, and T) effects on gut barrier function during PPI-induced dysbiosis using Triple-M-SHIME® model. Reactors were supplemented with PPI alone (PPI control); simultaneous PPI + A. clausii (preventive); and PPI for 2 weeks followed by A. clausii (curative). Caco-2/THP1-Blue™ co-cultures were exposed to colonic SHIME® suspensions for 24h for TEER measurement, followed by lipopolysaccharide stimulation for measurement of cytokine secretion and NF-κB. Preventive treatment didn’t improve inflammation-induced barrier disruption, but was slightly improved with curative treatment, particularly in the distal colon. Colonic ferments following A. clausii supplementation increased IL-10 secretion and pro-inflammatory signals in the ileum. In the proximal and distal colon, PPI treatment reduced pro-inflammatory markers during and after treatment, while increasing anti-inflammatory cytokines following prolonged incubation. Preventive treatment with A. clausii, reduced pro-inflammatory markers and IL-10, while increasing IL-6 secretion. Curative A. clausii treatment lowered pro-inflammatory markers. Enhanced colonic fermentation by A. clausii thus showed potential in improving gut barrier function and modulating inflammation with complex colon region-specific responses, particularly with curative treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ProDigest BV, 9052 Zwijnaarde, Belgium.
- Opella, Frankfurt, Germany.
- Opella, Neuilly-sur-Seine, France.
Förderung
- Opella
- Sanofi Consumer Healthcare
Zitieren
APA
Verstrepen, L., Duysburgh, C., Van den Broeck, M., Iii Perez, M., & Guyonnet, D. (2026). Impact of a blend of four Alkalihalobacillus clausii strains (O/C, N/R, SIN, and T) on gut barrier integrity and immune modulation with PPIs: An invitro SHIME study. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovag025
Vancouver
Verstrepen L, Duysburgh C, Van den Broeck M, Iii Perez M, Guyonnet D. Impact of a blend of four Alkalihalobacillus clausii strains (O/C, N/R, SIN, and T) on gut barrier integrity and immune modulation with PPIs: An invitro SHIME study. Letters in Applied Microbiology. 2026. doi:10.1093/lambio/ovag025
BibTeX
@article{Verstrepen2026,
author = {Verstrepen, Lynn and Duysburgh, Cindy and Van den Broeck, Mattia and Iii Perez, Marcos and Guyonnet, Denis},
title = {Impact of a blend of four Alkalihalobacillus clausii strains (O/C, N/R, SIN, and T) on gut barrier integrity and immune modulation with PPIs: An invitro SHIME study},
journal = {Letters in Applied Microbiology},
year = {2026},
doi = {10.1093/lambio/ovag025}
}
EUVIMED